Metabolism and physiologic roles of vitamin E

Area of Science:

• Neonatal nutrition
• Pediatric ophthalmology
• Neonatal pulmonology

Background:

• Premature infants fed formula with polyunsaturated fatty acids (PUFAs) and iron are at risk for hemolytic anemia.
• Tocopherol (vitamin E) is a key antioxidant with potential protective effects in neonates.
• Retinopathy of prematurity and bronchopulmonary dysplasia are significant morbidities in low-birthweight infants.

Purpose of the Study:

• To evaluate the antioxidant effect of vitamin E in preventing hemolytic anemia in low-birthweight infants.
• To assess the impact of tocopherol supplementation on retrolental fibroplasia and bronchopulmonary dysplasia.
• To explore the role of vitamin E in platelet function and its potential antithrombotic effects.

Main Methods:

• Observational study in low-birthweight infants fed specific formula.
• Administration of vitamin E (tocopherol) supplementation.
• Monitoring for hemolytic anemia, retrolental fibroplasia, and bronchopulmonary dysplasia.
• Assessment of platelet hyperaggregability.

Main Results:

• Vitamin E supplementation averted hemolytic anemia in infants fed formula rich in PUFAs and iron.
• Tocopherol decreased the incidence and severity of retrolental fibroplasia.
• Tocopherol supplementation reduced the development of bronchopulmonary dysplasia.
• Vitamin E lowered platelet hyperaggregability, but its antithrombotic role remains uncertain.

Conclusions:

• Vitamin E is crucial for preventing hemolytic anemia and reducing major complications in vulnerable low-birthweight infants.
• Tocopherol supplementation offers significant benefits for neonatal eye and lung health.
• Further research is needed to clarify the antithrombotic potential of vitamin E in this population.